The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | Therapies under investigation for mantle cell lymphoma
In this video, Krish Patel, MD, Providence Swedish Cancer Institute, Seattle, WA, briefly outlines novel therapies under investigation for the treatment of mantle cell lymphoma (MCL). Dr Patel mentions novel non-covalent BTK inhibitors, BTK degraders, bispecific antibodies, and alternative target CAR T-cell therapy. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
